| Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer SV Puram, I Tirosh, AS Parikh, AP Patel, K Yizhak, S Gillespie, C Rodman, ... Cell 171 (7), 1611-1624. e24, 2017 | 2007 | 2017 |
| Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology DG Pfister, S Spencer, D Adelstein, D Adkins, Y Anzai, DM Brizel, ... Journal of the National Comprehensive Cancer Network 18 (7), 873-898, 2020 | 903 | 2020 |
| p16 (MTS-1/CDKN2/INK4a) in cancer progression JW Rocco, D Sidransky Experimental cell research 264 (1), 42-55, 2001 | 720 | 2001 |
| NCCN guidelines insights: head and neck cancers, version 1.2018 AD Colevas, SS Yom, DG Pfister, S Spencer, D Adelstein, D Adkins, ... Journal of the National Comprehensive Cancer Network 16 (5), 479-490, 2018 | 578 | 2018 |
| Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists JS Lewis Jr, B Beadle, JA Bishop, RD Chernock, C Colasacco, ... Archives of pathology & laboratory medicine 142 (5), 559-597, 2018 | 535 | 2018 |
| p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis JW Rocco, CO Leong, N Kuperwasser, MP DeYoung, LW Ellisen Cancer cell 9 (1), 45-56, 2006 | 516 | 2006 |
| Head and neck cancer MD Mody, JW Rocco, SS Yom, RI Haddad, NF Saba The Lancet 398 (10318), 2289-2299, 2021 | 505 | 2021 |
| Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability K Akagi, J Li, TR Broutian, H Padilla-Nash, W Xiao, B Jiang, JW Rocco, ... Genome research 24 (2), 185-199, 2014 | 502 | 2014 |
| MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma EA Mroz, JW Rocco Oral oncology 49 (3), 211-215, 2013 | 357 | 2013 |
| NCCN guidelines insights: head and neck cancers, version 2.2017 D Adelstein, ML Gillison, DG Pfister, S Spencer, D Adkins, DM Brizel, ... Journal of the National Comprehensive Cancer Network 15 (6), 761-770, 2017 | 356 | 2017 |
| NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines JJ Caudell, ML Gillison, E Maghami, S Spencer, DG Pfister, D Adkins, ... Journal of the National Comprehensive Cancer Network 20 (3), 224-234, 2022 | 298 | 2022 |
| Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity GS Kinker, AC Greenwald, R Tal, Z Orlova, MS Cuoco, JM McFarland, ... Nature genetics 52 (11), 1208-1218, 2020 | 294 | 2020 |
| Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas EA Mroz, AM Tward, RJ Hammon, Y Ren, JW Rocco PLoS medicine 12 (2), e1001786, 2015 | 284 | 2015 |
| Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence T Keenan, B Moy, EA Mroz, K Ross, A Niemierko, JW Rocco, S Isakoff, ... Journal of Clinical Oncology 33 (31), 3621-3627, 2015 | 252 | 2015 |
| High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma EA Mroz, AD Tward, CR Pickering, JN Myers, RL Ferris, JW Rocco Cancer 119 (16), 3034-3042, 2013 | 237 | 2013 |
| Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma WA Michaud, AC Nichols, EA Mroz, WC Faquin, JR Clark, S Begum, ... Clinical cancer research 15 (5), 1645-1654, 2009 | 166 | 2009 |
| Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR EEW Cohen, MW Lingen, LE Martin, PL Harris, BW Brannigan, ... Clinical cancer research 11 (22), 8105-8108, 2005 | 164 | 2005 |
| p16 and p16β Are Potent Growth Suppressors of Head and Neck Squamous Carcinoma Cells in Vitro WH Liggett Jr, DA Sewell, J Rocco, SA Ahrendt, W Koch, D Sidransky Cancer Research 56 (18), 4119-4123, 1996 | 164 | 1996 |
| Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo EJ Morris, WA Michaud, JY Ji, NS Moon, JW Rocco, NJ Dyson PLoS genetics 2 (11), e196, 2006 | 147 | 2006 |
| iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry J Ryan, J Montero, J Rocco, A Letai Biological chemistry 397 (7), 671-678, 2016 | 138 | 2016 |
Stephen Y KangOhio State UniversityVerified email at osumc.edu
